MYPAQLIA Trademark

Trademark Overview

On Wednesday, May 1, 2019, a trademark application was filed for MYPAQLIA with the United States Patent and Trademark Office. The USPTO has given the MYPAQLIA trademark a serial number of 88411027. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 4, 2022. This trademark is owned by Athenex, Inc.. The MYPAQLIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs; Pharmaceutical preparations and drugs for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in the treatment of skin disorders, skin aliments and skin conditions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue
mypaqlia

General Information

Serial Number88411027
Word MarkMYPAQLIA
Filing DateWednesday, May 1, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs; Pharmaceutical preparations and drugs for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in the treatment of skin disorders, skin aliments and skin conditions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAthenex, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203
Party NameAthenex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 11, 2021SOU EXTENSION 4 GRANTED
Thursday, November 11, 2021SOU EXTENSION 4 FILED
Thursday, November 11, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021SOU EXTENSION 3 GRANTED
Friday, May 28, 2021SOU EXTENSION 3 FILED
Friday, May 28, 2021SOU TEAS EXTENSION RECEIVED
Thursday, November 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 24, 2020SOU EXTENSION 2 GRANTED
Tuesday, November 24, 2020SOU EXTENSION 2 FILED
Tuesday, November 24, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 24, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2020SOU EXTENSION 1 GRANTED
Friday, May 22, 2020SOU EXTENSION 1 FILED
Friday, May 22, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 23, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, July 23, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 23, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, July 23, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, July 15, 2019ASSIGNED TO EXAMINER
Tuesday, May 21, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, May 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 13, 2019ASSIGNED TO LIE
Monday, May 6, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, May 4, 2019NEW APPLICATION ENTERED

Related Keywords

mypaqlia pharmaceutical preparations drugs treatment skin disorders diseases oncology cancer aliments